Back to catalogue
GNS

Genus PLC

Health Care First-pass screen £1.6bn
420/1000 Overall fit
AI beneficiary 35% 15
Operating leverage 25% 50
Valuation 25% 70
Downside protection 15% 45

First-pass take

Cyclical agricultural genetics commodity business with zero AI exposure. Very cheap valuation (11.9x PER, 3.6% dividend yield), but farming cyclicality evident from recent EU policy disruption; FX-sensitive; tiny micro-cap.

Flags

cyclicalmicro-capfx-sensitivepolicy-riskno-ai-exposurestale-document